Monika L. Burness

发表

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells.

Hyeun Joong Yoon, Evan T. Keller, Eric Lin, 2017, Cell systems.

Interferon γ–Inducible Protein 10 Selectively Inhibits Proliferation and Induces Apoptosis in Endothelial Cells

A. Feldman, E. Turner, H. Alexander, 2006, Annals of Surgical Oncology.

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

M. Moravek, J. Jeruss, Pridvi Kandagatla, 2019, Annals of Surgical Oncology.

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Michael D. Brooks, M. Wicha, J. Colacino, 2016, Clinical Cancer Research.

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

J. Griggs, D. Hayes, E. Smith, 2020, Breast Cancer Research and Treatment.

High-Throughput Microﬂuidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells

M. Wicha, S. Fouladdel, E. Azizi, 2017 .

Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review

J. Jeruss, N. Henry, Monika L. Burness, 2022, Supportive Care in Cancer.

Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy

J. Griggs, D. Hayes, J. Rae, 2019, British journal of clinical pharmacology.

Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells

Woncheol Lee, Seungwon Jung, Riley Brien, 2019, Nature Communications.

Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis

M. Wicha, Monika L. Burness, 2018, Cell Research.

Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure.

J. Griggs, D. Hayes, K. Kidwell, 2019, Pharmacogenomics.

Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer: Promising Clinical Target or Only a Marker?

O. Olopade, T. Grushko, Monika L. Burness, 2010, Cancer journal.

Site-Specific Gene Expression Profiles and Novel Molecular Prognostic Factors in Patients with Lower Gastrointestinal Adenocarcinoma Diffusely Metastatic to Liver or Peritoneum

H. Alexander, Hui Xu, J. Pingpank, 2007, Annals of Surgical Oncology.

First-in-human phase I/II study of CYT-0851, a first-in-class inhibitor of RAD51-mediated homologous recombination in patients with advanced solid and hematologic cancers.

R. Advani, J. Bendell, P. Munster, 2021 .

Abstract P2-05-05: RAD51 inhibition using CYT-0851, shows anti-cancer activity in cellular models of breast cancer and acts synergistically with PARP inhibitors

K. Mills, Monika L. Burness, M. Day, 2020 .

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer.

Michael D. Brooks, Max S Wicha, M. Wicha, 2015, Cell stem cell.

Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone

C. McCall, H. Kim Lyerly, L. Olivere, 2016, Science Translational Medicine.

Phase 1 results of a phase 1/2 trial of CYT-0851, a first-in-class inhibitor of RAD51-mediated homologous recombination, in patients with advanced solid and hematologic cancers.

R. Advani, D. Siegel, D. Juric, 2022, Journal of Clinical Oncology.

Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report.

O. Olopade, E. Obeid, Monika L. Burness, 2015, Clinical Breast Cancer.

The stem cell niche in health and malignancy.

D. Sipkins, Monika L. Burness, 2010, Seminars in cancer biology.

Characterizing Circulating Tumor Cells Isolated from Metastatic Breast Cancer Patients Using Graphene Oxide Based Microfluidic Assay

Hyeun Joong Yoon, Lili Zhao, Yang Wang, 2018, Advanced biosystems.

Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells

E. Yoon, Yu-Chih Chen, Yu-Heng Cheng, 2019, Nature communications.

Metastatic Breast Cancer: Clinical Considerations

C. Poznak, Monika L. Burness, 2014 .

Treatment of Pregnancy-Associated Breast Cancer

Manali A. Bhave, Monika L. Burness, 2021, Current Breast Cancer Reports.

Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

O. Olopade, Monika L. Burness, 2011, Journal of Clinical Oncology.

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

J. Griggs, D. Hayes, E. Smith, 2018, Clinical Cancer Research.

Tunable Thermal‐Sensitive Polymer–Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells

N. Palanisamy, M. Wicha, E. Azizi, 2016, Advances in Materials.

EPHA genetics for prediction of paclitaxel-induced peripheral neuropathy sensitivity.

J. Griggs, D. Hayes, E. Smith, 2019, Journal of Clinical Oncology.

Identifying Barriers and Facilitators to Scalp Cooling Therapy Through a National Survey of the Awareness, Practice Patterns, and Attitudes of Oncologists

J. Jeruss, K. Kidwell, Monika L. Burness, 2021, JCO oncology practice.

Abstract 4226: Histone deacetylase inhibitors sensitize cancer stem cells to PARP inhibitors in triple-negative breast cancer

M. Wicha, L. Shang, Suling Liu, 2015 .

Tunable Thermal‐Sensitive Polymer–Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells

N. Palanisamy, M. Wicha, E. Azizi, 2016, Advanced materials.

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

R. Schilsky, C. Calfa, K. Gogineni, 2024, JCO precision oncology.